[go: up one dir, main page]

DE68919366D1 - Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen. - Google Patents

Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen.

Info

Publication number
DE68919366D1
DE68919366D1 DE68919366T DE68919366T DE68919366D1 DE 68919366 D1 DE68919366 D1 DE 68919366D1 DE 68919366 T DE68919366 T DE 68919366T DE 68919366 T DE68919366 T DE 68919366T DE 68919366 D1 DE68919366 D1 DE 68919366D1
Authority
DE
Germany
Prior art keywords
fissile
immunoconjugates
linkers
accumulation
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68919366T
Other languages
English (en)
Other versions
DE68919366T2 (de
Inventor
Paul Abrams
John Reno
Alan Fritzberg
Ananthachari Srinivasan
David Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Publication of DE68919366D1 publication Critical patent/DE68919366D1/de
Application granted granted Critical
Publication of DE68919366T2 publication Critical patent/DE68919366T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE68919366T 1988-09-30 1989-09-29 Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen. Expired - Fee Related DE68919366T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25190088A 1988-09-30 1988-09-30
PCT/US1989/004266 WO1990003188A1 (en) 1988-09-30 1989-09-29 Cleavable linkers for the reduction of non-target organ retention of immunoconjugates

Publications (2)

Publication Number Publication Date
DE68919366D1 true DE68919366D1 (de) 1994-12-15
DE68919366T2 DE68919366T2 (de) 1995-05-18

Family

ID=22953869

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68919366T Expired - Fee Related DE68919366T2 (de) 1988-09-30 1989-09-29 Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen.

Country Status (3)

Country Link
EP (1) EP0436664B1 (de)
DE (1) DE68919366T2 (de)
WO (1) WO1990003188A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112953A (en) * 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates
US5776458A (en) * 1990-12-05 1998-07-07 Pharmacia & Upjohn S.P.A. Anthracycline-conjugates
WO1992019274A1 (en) * 1991-05-08 1992-11-12 Mallinckrodt Medical, Inc. Technetium chelates to be used for determining the renal function
US5505931A (en) * 1993-03-04 1996-04-09 The Dow Chemical Company Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
US6214345B1 (en) * 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
EP0647450A1 (de) * 1993-09-09 1995-04-12 BEHRINGWERKE Aktiengesellschaft Verbesserte Prodrogen für Enzym-vermittelten-Aktivierungen
US5804158A (en) * 1995-05-31 1998-09-08 Resolution Pharmaceuticals Inc. Sequestered imaging agents
JP2000503639A (ja) * 1995-12-22 2000-03-28 ブリストル―マイヤーズ スクイブ カンパニー 分枝ヒドラゾンのリンカー類
AU2016334401A1 (en) * 2015-10-10 2018-04-26 Intrexon Corporation Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519714A (de) * 1974-06-04 1976-01-26 Wellcome Found
US4081246A (en) * 1976-05-03 1978-03-28 Beckman Instruments, Inc. Solid phase column immunoassay procedure employing novel immunochemical composites
EP0044167A3 (de) * 1980-07-14 1982-04-21 The Regents Of The University Of California Durch einen Antikörper gerichtetes zytotoxisches Mittel
US4631190A (en) * 1981-06-26 1986-12-23 Shen Wei C Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers
FR2516794B1 (fr) * 1981-11-20 1985-10-25 Sanofi Sa Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
JPS59116229A (ja) * 1982-12-24 1984-07-05 Teijin Ltd 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法
JPS6067433A (ja) * 1983-09-24 1985-04-17 Kyowa Hakko Kogyo Co Ltd マイトマイシン類，多糖類及び抗体の複合体
US4647671A (en) * 1985-01-25 1987-03-03 Schwartz Martin A Cleavable cross-linking reagent
US4698420A (en) * 1985-02-25 1987-10-06 Xoma Corporation Antibody hybrid molecules and process for their preparation
ATE52516T1 (de) * 1986-05-28 1990-05-15 Mallinckrodt Inc Technetiumchelate fuer die bestimmung der nierenfunktion.
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies

Also Published As

Publication number Publication date
EP0436664A4 (en) 1992-04-22
EP0436664B1 (de) 1994-11-09
EP0436664A1 (de) 1991-07-17
DE68919366T2 (de) 1995-05-18
WO1990003188A1 (en) 1990-04-05

Similar Documents

Publication Publication Date Title
TR23569A (tr) Tuetuenuen yeniden yapilmasinda islahat
KR900002241U (ko) 전지 가위
DK384889D0 (da) Forbedringer relateret til enzymer
DE3876997D1 (de) Konjugate von superoxiddismutase.
FI882334A0 (fi) Foerbaettrad polyetylenfibermassa.
DE68919366D1 (de) Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen.
IT8722711A0 (it) Derivati cationizzati polisaccaridi ad attivita'ipocolesterolemizzante.
DE3850279D1 (de) Der Bewitterung ausgesetzte Anstriche.
FI925869L (fi) Foerfarande foer infoerande av en peptid i cytosol
DK539888A (da) Ballepresser
NO890356D0 (no) Fremgangsmaate til aa utfoere vei- og markkonstruksjoner.
IT8522688V0 (it) Iniziatore in prossimita' ad ultrasuoni.
DE68918033D1 (de) Schutz zur Abnutzungsverringerung von Fingerhutrohren.
IT8722218A0 (it) Ftalazino derivati ad attivita'farmaceutica.
DK181588A (da) Shampoosammensaetning
IT1203968B (it) Complessi di b-ciclodestrina ad attivita' antimicotica
FI881648A0 (fi) Shampookoostumuksia
FR2624362B1 (fr) Meuble jardiniere
KR890022333U (ko) 경운기에 부착되는 분무기 받침대
ES1008293Y (es) Preparador vibrador de hojas que han de ser encuadernadas.
KR910011747U (ko) 중형지하출입문
FI903102A0 (fi) Taetad takgenomgaong.
NO169999C (no) Langrennsski
KR900010033U (ko) 경운기용 트레일러
KR890020510U (ko) 착용이 쉽고 간편한 넥타이

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee